Main Article Content
Abstract
Uterine artery embolization (UAE) is currently widely used in gynecological practice and is an alternative to hysterectomy in women with symptomatic uterine myoma. The decision to perform UAE in women with large and giant uterine fibroids is, in most cases, extremely difficult due to the potential risk of serious postoperative complications. This article presents the case of a favorable outcome after the EMA in a 45 year-patient with the giant myoma node who refused to have surgery and hysterectomy.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol. 2005; 48: 312-324
Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004; 104: 393-406
Istre O. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. Best Pract Res Clin Obstet Gynaecol. 2008; 22(4): 735-747
Levai AM, Rotar IC, Muresan D. Torsion of a uterineleiomyoma – a rare cause of hemoperitoneum; a case report and review of the literature. Med Ultrason. 2019; 21(1): 77-82
Sidorova I.S. Uterine fibroids. M: Medical Information Agency, 2003. 256 p. Russian (Сидорова И.С. Миома матки. М: Медицинское информационное агентство, 2003. 256 с.)
Tong C, Wang Y, Liu Z, Zhao Y, Xu Y, Wang W. Spontaneous reduction of an incarcerated gravid uterus after myomectomy in the second trimester: A case report. Medicine (Baltimore). 2019; 98(9): e14731
Lotterman S. Massive hemoperitoneum resulting from spontaneous rupture of uterineleiomyoma. Am J Emerg Med. 2008; 26(8): 974.e1-2
Althobaiti FA, Alsaadi KK, Althobaiti AA. A Case of Hemoperitoneum Due to Spontaneous Bleeding from a Uterine Leiomyoma. Am J Case Rep. 2019; 20: 167-170
van der Kooij SM, Ankum WM, Hehenkamp WJ. Review of nonsurgical/minimally invasive treatments for uterine fibroids. Curr Opin Obstet Gynecol. 2012 Dec; 24(6): 368-375
Stovall DW. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound. Menopause. 2011; 18(4): 437-444
Taheri M, Galo L, Potts C, Sakhel K, Quinn SD. Nonresective treatments for uterine fibroids: a systematic review of uterine and fibroid volume reductions. Int J Hyperthermia. 2019; 1: 1-7
Marshburn PB, Matthews ML, Hurst BS. Uterine artery embolization as a treatment option for uterine myomas. Obstet Gynecol Clin North Am. 2006; 33(1): 125-144
Tikhomirov AL. Myoma. Pathogenetic rationale for conservative treatment. M: CJSC Farm-synthesis, 2013. 319 p. Russian (Тихомиров А.Л. Миома. Патогенетическое обоснование органосохраняющего лечения. М: ЗАО Фарм-синтез, 2013. 319 с.)
Zurawin RK, Fischer JH 2nd, Amir L. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma. J Minim Invasive Gynecol. 2010; 17(2): 214-221
Chung YJ, Kang SY, Chun HJ, Rha SE, Cho HH, Kim JH, Kim MR. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization. Int J Med Sci. 2018; 15(14): 1771-1777
Scheurig-Muenkler C, Koesters C, Powerski MJ, Grieser C, Froeling V, Kroencke TJ. Clinical long-term outcome after uterine artery embolization: sustained symptom control and improvement of quality of life. J Vasc Interv Radiol. 2013; 24: 765-771